breast cancer treatment

A New Therapy for Metastatic Breast Cancer | News Brief

June 8, 2012

The FDA has approved pertuzumab (Perjeta, Genentech) for the treatment of patients with HER2-positive metastatic breast cancer. The therapy is intended for use in combination with docetaxel and trastuzumab in patients who have not received prior treatment for their disease with an anti-HER2 therapy or chemotherapy.…

Important Decisions in Breast Cancer Surgery | Feature

June 1, 2011

New research indicates that patients with breast cancer are more likely to receive breast reconstruction when plastic surgeons are involved as part of the treatment decision team.